Treatment of Rosacea
For rosacea treatment, use a phenotype-directed approach: topical azelaic acid or ivermectin for mild-to-moderate papules/pustules, oral doxycycline 40 mg for moderate-to-severe inflammatory disease, and reserve isotretinoin for severe refractory cases. 1
General Skincare Foundation (All Patients)
Before initiating pharmacotherapy, establish these baseline measures 1:
- SPF 30+ sunscreen daily
- Gentle cleansers (avoid harsh scrubs)
- Moisturizers for barrier support
- Trigger avoidance (alcohol, spicy foods, temperature extremes, stress)
First-Line Topical Therapies by Phenotype
For Inflammatory Papules/Pustules
Mild disease:
- Topical ivermectin or azelaic acid are first-line choices with high-certainty evidence 2
- Topical metronidazole is an alternative with moderate-certainty evidence 2
- Topical minocycline foam is also effective 3
Moderate disease:
- Continue topical ivermectin or azelaic acid
- Consider adding oral doxycycline 40 mg modified-release if topical therapy insufficient 1
Severe disease:
- Oral doxycycline 40 mg (high-certainty evidence, noninferior to 100 mg dosing) 1, 2
- Oral isotretinoin for refractory cases 1
For Persistent Erythema
- Topical brimonidine (high-certainty evidence) 2
- Topical oxymetazoline (moderate-certainty evidence) 2
- These provide symptomatic relief through vasoconstriction 4
For Telangiectasia
- Laser therapy (intense pulsed light or pulsed-dye laser) with low-to-moderate certainty evidence 2
- Electrodessication for isolated vessels 1
For Phymatous Changes
- Clinically inflamed phyma: Oral doxycycline 1
- Clinically noninflamed ("burnt out") phyma: Physical modalities (surgical resection, laser ablation, dermabrasion) 1
Indications for Oral Antibiotics
Prescribe oral doxycycline 40 mg modified-release when 1, 4, 2:
- Moderate-to-severe papulopustular disease
- Inadequate response to topical monotherapy
- Extensive facial involvement
- Patient preference for systemic therapy
Key advantage: Doxycycline 40 mg provides anti-inflammatory effects without antimicrobial resistance concerns at this sub-antimicrobial dose 1.
Alternative oral antibiotics include 4, 2:
- Minocycline (moderate-certainty evidence, equally effective as doxycycline 40 mg)
- Tetracycline (low-certainty evidence)
Indications for Isotretinoin
Reserve oral isotretinoin for 1, 5:
- Severe recalcitrant nodular rosacea unresponsive to conventional therapy including systemic antibiotics 5
- Severe papulopustular disease refractory to doxycycline
- Moderate-to-high certainty evidence supports efficacy 2
Critical caveat: Isotretinoin is FDA-indicated for "severe recalcitrant nodular acne" but used off-label for rosacea 5. It causes life-threatening birth defects and requires strict pregnancy prevention 5. Consider low-dose isotretinoin (0.3-0.5 mg/kg/day) rather than standard acne dosing 4.
Combination Therapy Strategy
Multiple features can be treated simultaneously 1:
- Persistent erythema + papules/pustules: Topical brimonidine + topical ivermectin 6
- Moderate-to-severe inflammatory disease: Topical metronidazole + oral doxycycline 6
- Moderate and severe presentations typically require combination approaches 1
If first-line treatment fails: Either switch to an alternative first-line option or add another first-line agent 1.
Maintenance Therapy
Once control is achieved 1:
- Use minimum treatment necessary to maintain control
- Topical metronidazole, ivermectin, or azelaic acid are appropriate for long-term maintenance 6
- Allow sufficient duration (treatment-specific) before switching therapies
- Tailor to patient desire for ongoing therapy
Ocular Rosacea Management
Mild symptoms (burning/stinging):
- Lid hygiene
- Artificial tear substitutes 1
Moderate-to-severe symptoms:
- Refer to ophthalmology if not controlled with lid hygiene 1
- Oral omega-3 fatty acids (moderate-certainty evidence) 2, 6
- Cyclosporine ophthalmic emulsion (low-certainty evidence) 2, 6
Common Pitfalls to Avoid
- Don't use high-dose doxycycline (100 mg) when 40 mg modified-release is equally effective with better tolerability 1
- Don't prescribe isotretinoin without ensuring pregnancy prevention in women of childbearing potential 5
- Don't treat telangiectasia with topical medications alone—these require procedural interventions 1
- Don't delay combination therapy in moderate-to-severe disease; monotherapy is often insufficient 1
- Don't overlook ocular symptoms—ask specifically about eye irritation, as patients may not volunteer this information 1